Javle M - Search Results

1

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.

Javle M, Lowery M, Shroff RT, Weiss KH, Springfeld C, Borad MJ, Ramanathan RK, Goyal L, Sadeghi S, Macarulla T, El-Khoueiry A, Kelley RK, Borbath I, Choo SP, Oh DY, Philip PA, Chen LT, Reungwetwattana T, Van Cutsem E, Yeh KH, Ciombor K, Finn RS, Patel A, Sen S, Porter D, Isaacs R, Zhu AX, Abou-Alfa GK, Bekaii-Saab T. Javle M, et al. J Clin Oncol. 2018 Jan 20;36(3):276-282. doi: 10.1200/JCO.2017.75.5009. Epub 2017 Nov 28. J Clin Oncol. 2018. PMID: 29182496 Free PMC article. Clinical Trial.

2

CD24 expression is an independent prognostic marker in cholangiocarcinoma.

Agrawal S, Kuvshinoff BW, Khoury T, Yu J, Javle MM, LeVea C, Groth J, Coignet LJ, Gibbs JF. Agrawal S, et al. Among authors: javle mm. J Gastrointest Surg. 2007 Apr;11(4):445-51. doi: 10.1007/s11605-007-0091-5. J Gastrointest Surg. 2007. PMID: 17436128 Free PMC article.

3

A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective study.

Iyer RV, Gibbs J, Kuvshinoff B, Fakih M, Kepner J, Soehnlein N, Lawrence D, Javle MM. Iyer RV, et al. Among authors: javle mm. Ann Surg Oncol. 2007 Nov;14(11):3202-9. doi: 10.1245/s10434-007-9539-9. Epub 2007 Aug 19. Ann Surg Oncol. 2007. PMID: 17705089 Clinical Trial.

4

Capecitabine plus 3-weekly irinotecan (XELIRI regimen) as first-line chemotherapy for metastatic colorectal cancer: phase II trial results.

Patt YZ, Lee FC, Liebmann JE, Diamandidis D, Eckhardt SG, Javle M, Justice GR, Keiser W, Salvatore JR, Bexon A, Lin E. Patt YZ, et al. Among authors: javle m. Am J Clin Oncol. 2007 Aug;30(4):350-7. doi: 10.1097/COC.0b013e31804b40bb. Am J Clin Oncol. 2007. PMID: 17762434 Clinical Trial.

5

Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect predicts clinical response.

Javle M, Pande A, Iyer R, Yang G, LeVea C, Wilding G, Black J, Nava H, Nwogu C. Javle M, et al. Am J Clin Oncol. 2008 Aug;31(4):329-34. doi: 10.1097/COC.0b013e318161dc04. Am J Clin Oncol. 2008. PMID: 18845990 Clinical Trial.

6

A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer.

El-Rayes BF, Philip PA, Sarkar FH, Shields AF, Ferris AM, Hess K, Kaseb AO, Javle MM, Varadhachary GR, Wolff RA, Abbruzzese JL. El-Rayes BF, et al. Among authors: javle mm. Invest New Drugs. 2011 Aug;29(4):694-9. doi: 10.1007/s10637-010-9386-6. Epub 2010 Jan 27. Invest New Drugs. 2011. PMID: 20107864 Clinical Trial.

7

A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas.

Lo SS, Khorana AA, Javle M, Simon S, Kiefer G, Rajasenan K, Wang H, Hantel A, Shayne M, Hwang J, Schmotzer A, Ramanathan RK. Lo SS, et al. Among authors: javle m. Oncology. 2010;78(2):125-9. doi: 10.1159/000312654. Epub 2010 Apr 13. Oncology. 2010. PMID: 20389134 Clinical Trial.

8

Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer.

Dong X, Javle M, Hess KR, Shroff R, Abbruzzese JL, Li D. Dong X, et al. Among authors: javle m. Gastroenterology. 2010 Aug;139(2):464-73, 473.e1-3. doi: 10.1053/j.gastro.2010.04.042. Epub 2010 Apr 21. Gastroenterology. 2010. PMID: 20416304 Free PMC article.

9

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies.

Javle MM, Shroff RT, Xiong H, Varadhachary GA, Fogelman D, Reddy SA, Davis D, Zhang Y, Wolff RA, Abbruzzese JL. Javle MM, et al. BMC Cancer. 2010 Jul 14;10:368. doi: 10.1186/1471-2407-10-368. BMC Cancer. 2010. PMID: 20630061 Free PMC article. Clinical Trial.

10

Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.

Crane CH, Varadhachary GR, Yordy JS, Staerkel GA, Javle MM, Safran H, Haque W, Hobbs BD, Krishnan S, Fleming JB, Das P, Lee JE, Abbruzzese JL, Wolff RA. Crane CH, et al. Among authors: javle mm. J Clin Oncol. 2011 Aug 1;29(22):3037-43. doi: 10.1200/JCO.2010.33.8038. Epub 2011 Jun 27. J Clin Oncol. 2011. PMID: 21709185 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

271 results

Search Page